11/14/2025
Real Progress. Real Results.
There are lingering myths around oral immunotherapy (OIT).
Here are the facts from our data and the largest clinic-based study of OIT, conducted by Weill Cornell Medicine and Latitude Food Allergy Care:
MYTH: OIT causes constant, scary reactions.
FACT: Reactions during dosing are uncommon and didn't derail treatment schedules. Only 5% of doses in over 1,000 patients caused any reaction, and the overwhelming majority were mild, like an itchy mouth or stomachache.
MYTH: OIT takes over your family’s schedule.
FACT: On average, patients reach desensitization to many common food allergies in just 8.5 months, with clinic visits every two weeks.
MYTH: OIT is only effective for young children and adults cannot be treated.
FACT: At Latitude 97% of patients under the age of 4 successfully reach maintenance, and 92% of patients of all ages reach maintenance. Our data validated in the Weill Cornell study included patients from 0-47 years old, and our overall current data includes patients 0-68 years old.
MYTH: Allergy clinics keep results in a black box, and only self-report.
FACT: Latitude shared clinical data from over 1,000 patients with Weill Cornell, ensuring results were validated, published, and advanced. The initial findings were presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting earlier this year, for all allergists to learn from. And with the largest private-practice OIT dataset in the country, we will continue to evaluate and share our data to continue to improve patient care.
The FACTS: OIT means families can keep living their lives while gaining protection. OIT is safe. OIT is effective.
Every family deserves a life without limits from food allergies. That’s why we’re committed to transparency and on a mission to provide access to expert care for every family living with food allergies.
📲Learn more at the links in our bio and share this post to help others see what’s possible.
Real Progress. Real Results.
There are lingering myths around oral immunotherapy (OIT).
Here are the facts from our data and the largest clinic-based study of OIT, conducted by Weill Cornell Medicine and Latitude Food Allergy Care:
MYTH: OIT causes constant, scary reactions.
FACT: Reactions during dosing are uncommon and didn't derail treatment schedules. Only 5% of doses in over 1,000 patients caused any reaction, and the overwhelming majority were mild, like an itchy mouth or stomachache.
MYTH: OIT takes over your family’s schedule.
FACT: On average, patients reach desensitization to many common food allergies in just 8.5 months, with clinic visits every two weeks.
MYTH: OIT is only effective for young children and adults cannot be treated.
FACT: At Latitude 97% of patients under the age of 4 successfully reach maintenance, and 92% of patients of all ages reach maintenance. Our data validated in the Weill Cornell study included patients from 0-47 years old, and our overall current data includes patients 0-68 years old.
MYTH: Allergy clinics keep results in a black box, and only self-report.
FACT: Latitude shared clinical data from over 1,000 patients with Weill Cornell, ensuring results were validated, published, and advanced. The initial findings were presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting earlier this year, for all allergists to learn from. And with the largest private-practice OIT dataset in the country, we will continue to evaluate and share our data to continue to improve patient care.
The FACTS: OIT means families can keep living their lives while gaining protection. OIT is safe. OIT is effective.
Every family deserves a life without limits from food allergies. That’s why we’re committed to transparency and on a mission to provide access to expert care for every family living with food allergies.
📣Share this post to help others see what’s possible.
🔗And read more about the published data from Latitude and Weill Cornell here:
https://www.prnewswire.com/news-releases/latitude-food-allergy-care-announces-findings-of-large-scale-study-led-by-weill-cornell-medicine-validating-safety-and-effectiveness-of-oral-immunotherapy-oit-for-food-allergies-in-clinical-practice-302387612.html
